SuperworthZimmer Biomet profit margin ZBH
Gross, operating and net profit as a share of revenue over the last twelve months, from 2009.
- Net margin, 12 months
- 9.5%
- Operating margin, 12 months
- 14.2%
- Net margin on a year earlier
- −1.0 pts
- Peer median
- 14.4%
Over the twelve months to Jun 30, 2026, Zimmer Biomet kept 9.5% of its revenue as net profit, with an operating margin of 14.2% and a gross margin of 69.9%.
Five years earlier its net margin was 12.4%.
The median for 10 medical device stocks of a similar size is 14.4%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 8.6% | 13.3% | 69.7% |
| FY2024 | 11.8% | 16.7% | 71.5% |
| FY2023 | 13.8% | 17.3% | 71.8% |
| FY2022 | 3.3% | 10.0% | 70.9% |
| FY2021 | 5.9% | 12.6% | 71.3% |
| FY2020 | −2.0% | −1.2% | 69.7% |
| FY2019 | 14.2% | 14.3% | 71.8% |
| FY2018 | −4.8% | 0.4% | 71.4% |
| FY2017 | 23.2% | 10.2% | 72.7% |
| FY2016 | 4.0% | 10.7% | 69.0% |
| FY2015 | 2.5% | 7.8% | 70.0% |
| FY2014 | 15.4% | 22.3% | 73.4% |
| FY2013 | 16.5% | 22.4% | 72.2% |
| FY2012 | 16.9% | 23.4% | 74.8% |
| FY2011 | 17.1% | 23.0% | 74.8% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 9.5% | −1.0 pts | 14.2% | |
| Q1 FY26 | 9.1% | −2.8 pts | 14.0% | |
| Q4 FY25 | 8.6% | −3.2 pts | 13.3% | |
| Q3 FY25 | 10.1% | −4.2 pts | 16.6% | |
| Q2 FY25 | 10.5% | −2.7 pts | 16.1% | |
| Q1 FY25 | 11.9% | −1.1 pts | 17.0% | |
| Q4 FY24 | 11.8% | −2.1 pts | 16.7% | |
| Q3 FY24 | 14.3% | +7.7 pts | 16.5% | |
| Q2 FY24 | 13.3% | +6.2 pts | 16.5% | |
| Q1 FY24 | 12.9% | +6.6 pts | 16.3% | |
| Q4 FY23 | 13.8% | +10.5 pts | 17.3% | |
| Q3 FY23 | 6.5% | +2.5 pts | 12.3% |
Against its peers
Companies in Medical - Devices nearest Zimmer Biomet's size, closest first, today.
| Company | Profit margin |
|---|---|
| ZBHZimmer Biomet | 9.5% |
| DXCMDexCom | 20.1% |
| GEHCGE HealthCare Technologies | 9.3% |
| EWEdwards Lifesciences | 15.4% |
| BSXBoston Scientific | 17.5% |
| LIVNLivaNova | 12.8% |
| ITGRInteger | 7.0% |
| SYKStryker | 14.4% |
| MDTMedtronic | 13.9% |
| TMDXTransMedics | 22.7% |
| ABTAbbott Laboratories | n/m |
| Peer median | 14.4% |
Where Zimmer Biomet ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Zimmer Biomet
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.